CA2199131C - Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes - Google Patents
Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes Download PDFInfo
- Publication number
- CA2199131C CA2199131C CA002199131A CA2199131A CA2199131C CA 2199131 C CA2199131 C CA 2199131C CA 002199131 A CA002199131 A CA 002199131A CA 2199131 A CA2199131 A CA 2199131A CA 2199131 C CA2199131 C CA 2199131C
- Authority
- CA
- Canada
- Prior art keywords
- virus
- region
- mesv
- binding site
- ltr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Hybrides vectoriels rétroviraux à défauts de réplication, caractérisés en ce qu'ils contiennent a) dans la région leader, comme région U5 et/ou comme site de liaison amorce tRNA, la région U5 et/ou le site de liaison amorce tRNA de MESV et, b) comme régions U3 et R en 3'-LTR, les régions U3 et R d'un virus de leucémie murine Friend (F-MuLV). Les hybrides selon l'invention sont particulièrement appropriés pour un transfert efficace de gènes dans des cellules souches hématopoïétiques.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4431973.8 | 1994-09-08 | ||
DE4431973 | 1994-09-08 | ||
DE19503952A DE19503952A1 (de) | 1994-09-08 | 1995-02-07 | Retrovirale Vektorhybride und deren Verwendung zum Gentransfer |
DE19503952.1 | 1995-02-07 | ||
PCT/EP1995/003175 WO1996007747A1 (fr) | 1994-09-08 | 1995-08-10 | Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2199131A1 CA2199131A1 (fr) | 1996-03-14 |
CA2199131C true CA2199131C (fr) | 2007-04-10 |
Family
ID=38007181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002199131A Expired - Fee Related CA2199131C (fr) | 1994-09-08 | 1995-08-10 | Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2199131C (fr) |
-
1995
- 1995-08-10 CA CA002199131A patent/CA2199131C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2199131A1 (fr) | 1996-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5714353A (en) | Safe vectors for gene therapy | |
US6949242B2 (en) | Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells | |
US5858744A (en) | Retroviral vector hybrids and the use thereof for gene transfer | |
US6027722A (en) | Vectors for gene transfer | |
US6013517A (en) | Crossless retroviral vectors | |
US5747323A (en) | Retroviral vectors comprising a VL30-derived psi region | |
CA2160034C (fr) | Vecteurs retroviraux a base du virus de la leucemie du gibbon | |
JP2001502903A (ja) | レンチウィルスベクター | |
EP0953052A1 (fr) | Vecteurs retroviraux sans croisement | |
JPH09500783A (ja) | シトシンデアミナーゼ(cd)遺伝子に基づく二機能性選択融合遺伝子 | |
EP0688358A1 (fr) | Vecteurs ameliores en therapie genique | |
US5710037A (en) | Retroviral vector particles | |
US5698446A (en) | Methods and compositions for inhibiting production of replication competent virus | |
Beck-Engeser et al. | Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells | |
WO1995034639A9 (fr) | Nouvelle enveloppe retrovirale et long segment terminal a repetitions (ltr) et particules de vecteur retroviral comprenant cette enveloppe et/ou le ltr | |
EP2669378A1 (fr) | Système de gène suicide du cytochrome P450 | |
Couture et al. | Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression | |
JP2002542834A (ja) | レトロウイルスベクターでのires転写カセットからの異種遺伝子群の発現 | |
US5631162A (en) | Retroviral vectors for transducing β-globin gene and β-locus control region derivatives | |
Haviernik et al. | Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors | |
EP0835320A1 (fr) | Ameliorations apportees a des vecteurs retroviraux, appropries en particulier pour la therapie genique | |
CA2199131C (fr) | Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes | |
JPH11507244A (ja) | Srv−3エンベロープ糖タンパク質配列で偽型化したレトロウイルスベクター | |
WO1997007223A1 (fr) | Vecteurs a auto-suppression pour therapie genique | |
Kaptein et al. | Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |